IGF-II receptor number is increased in TE-85 osteosarcoma cells by combined magnetic fields.

Fitzsimmons, R J; Ryaby, J T; Magee, F P; Baylink, D J

Fitzsimmons, R J; Ryaby, J T; Magee, F P; Baylink, D J.

Affiliation

Fitzsimmons RJ; Department of Research, Jerry L. Pettis Memorial VA Hospital, Loma Linda, California, USA.

J Bone Miner Res ; 10(5): 812-9, 1995 May.

Article in En | MEDLINE | ID: mdl-7639117

Subject(s)

Electromagnetic Fields; Insulin-Like Growth Factor II/pharmacology; Insulin-Like Growth Factor I/pharmacology; Osteoblasts/physiology; Receptor, IGF Type 2/metabolism; Analysis of Variance; Binding, Competitive; Bone Development/physiology; Bone Neoplasms/pathology; Bone Remodeling/physiology; Cell Division/drug effects; DNA/biosynthesis; Dose-Response Relationship, Drug; Electromagnetic Fields/adverse effects; Humans; Insulin-Like Growth Factor I/metabolism; Insulin-Like Growth Factor II/metabolism; Osteoblasts/cytology; Osteosarcoma/pathology; Receptor, IGF Type 2/drug effects; Receptor, IGF Type 2/physiology; Signal Transduction; Tumor Cells, Cultured

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Osteoblasts / Insulin-Like Growth Factor I / Insulin-Like Growth Factor II / Receptor, IGF Type 2 / Electromagnetic Fields Limits: Humans Language: En Journal: J Bone Miner Res Journal subject: METABOLISMO / ORTOPEDIA Year: 1995 Document type: Article Affiliation country: United States Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links